Dyne Therapeutics, Inc. - Common Stock (NQ:DYN)

15.70 +0.08 (+0.51%)

Delayed Quote Updated: 2:51 PM EDT, Oct 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Dyne Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Crude Oil Moves Lower; Walgreens Posts Upbeat Earnings ↗

January 04, 2024

U.S. stocks traded mixed toward the end of trading, with the Dow Jones index gaining over 100 points on Thursday. The Dow traded up 0.33% to 37,554.56 while the NASDAQ fell 0.10% to 14,578.04. The S&P...

Via Benzinga

Topics Stocks

Dyne Therapeutics Inc. (NASDAQ: DYN) Leading the Way in Thursday Trading Based on Percentage Gain

January 04, 2024

Via Investor Brand Network

Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

January 04, 2024

Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance.<

Via Benzinga

Why Shares of Dyne Therapeutics Fell This Week ↗

September 15, 2023

Insiders sold more than 15,000 shares of company stock on Tuesday.

Via The Motley Fool

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 04, 2024

Via Benzinga

Dow Surges 200 Points; US Services PMI Edges Higher In December ↗

January 04, 2024

U.S. stocks traded mostly higher midway through trading, with the Dow Jones index gaining around 200 points on Thursday. The Dow traded up 0.55% to 37,635.05 while the NASDAQ rose 0.05% to 14,599.10....

Via Benzinga

Topics Stocks

Lamb Weston Posts Upbeat Results, Joins Omega Therapeutics, Allstate And Other Big Stocks Moving Higher On Thursday ↗

January 04, 2024

U.S. stocks traded mostly higher, with the Dow Jones index gaining around 150 points on Thursday. Shares of Lamb Weston Holdings, Inc. (NYSE: LW) rose during Thursday’s session following...

Via Benzinga

Topics Stocks

Cal-Maine Posts Downbeat Q2 Results, Joins Dyne Therapeutics, OPKO Health And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

January 04, 2024

U.S. stock futures were higher this morning, with the Dow Jones futures gaining around 50 points on Thursday.

Via Benzinga

Topics Stocks

Dyne Therapeutics Announces Proposed Public Offering of Common Stock

January 03, 2024

From Dyne Therapeutics, Inc.

Via GlobeNewswire

Why SoFi Technologies Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 03, 2024

Shares of SoFi Technologies, Inc. (NASDAQ: SOFI) fell sharply during Wednesday’s session after Keefe, Bruyette & Woods downgraded rating on the stock.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

January 03, 2024

Via Benzinga

TDCX Receives Preliminary Non-binding Proposal Letter, Joins Pure Storage, Dyne Therapeutics And Other Big Stocks Moving Higher On Wednesday ↗

January 03, 2024

U.S. stocks traded lower, with the Nasdaq Composite falling around 150 points on Wednesday. Shares of TDCX Inc. (NYSE: TDCX) rose sharply during Wednesday’s session after it disclosed receiving a...

Via Benzinga

Topics Stocks

Why Is Pinstripes (PNST) Stock Down 12% Today? ↗

January 03, 2024

Pinstripes stock is sliding lower on Wednesday as shares of PNST give up some of the gains they saw during their public debut yesterday.

Via InvestorPlace

Why Is Flex (FLEX) Stock Moving Today? ↗

January 03, 2024

Flex stock is on the move Wednesday after the company completed its spinoff of Nextracker by distributing its stake to holders of its stock.

Via InvestorPlace

Why Is Trinity Place (TPHS) Stock Up 97% Today? ↗

January 03, 2024

Trinity Place stock is up on Wednesday as investors in TPHS react to a new forbearance agreement update with heavy trading of the shares.

Via InvestorPlace

Why Is Dyne Therapeutics (DYN) Stock Up 39% Today? ↗

January 03, 2024

Dyne Therapeutics stock is rising higher on Wednesday as investors in DYN react to positive clinical trial news from the company.

Via InvestorPlace

Why Is Rare Muscle Disease-Focused Dyne Therapeutics Stock Soaring Today? ↗

January 03, 2024

Dyne Therapeutics Inc (NASDAQ: DYN) released initial clinical data from its ACHIEVE trial of DYNE-101 in patients with myotonic dystrophy type 1 (DM1) and its DELIVER trial of DYNE-251 in patients with...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 03, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

January 03, 2024

It's time to dive into the biggest pre-market stock movers with all of the latest coverage worth reading about on Wednesday morning!

Via InvestorPlace

Dyne Therapeutics Announces Positive Initial Clinical Data from ACHIEVE Trial in DM1 Patients and DELIVER Trial in DMD Patients Demonstrating Promise of the FORCE™ Platform in Developing Therapeutics for Rare Muscle Diseases

January 03, 2024

From Dyne Therapeutics, Inc.

Via GlobeNewswire

Dyne Therapeutics to Host Virtual Event Tomorrow, January 3 at 8:00 AM ET, to Present Initial Clinical Data from ACHIEVE and DELIVER Trials

January 02, 2024

From Dyne Therapeutics, Inc.

Via GlobeNewswire

3 of the Best Cheap Stocks Under $20 to Buy Now: November Edition ↗

November 13, 2023

After dropping to 52-week lows, the markets have been rallying, sending traders and investors are looking for cheap stocks under $20.

Via InvestorPlace

Dyne Therapeutics to Present at November Investor Conferences

November 07, 2023

From Dyne Therapeutics, Inc.

Via GlobeNewswire

Dyne Therapeutics Reports Third Quarter 2023 Financial Results and Provides Update on Significant Progress for ACHIEVE and DELIVER Trials and Upcoming Clinical Milestones

October 30, 2023

From Dyne Therapeutics, Inc.

Via GlobeNewswire

Dyne Therapeutics to Present at October Investor Conferences

September 28, 2023

From Dyne Therapeutics, Inc.

Via GlobeNewswire

Dyne Therapeutics Receives FDA Orphan Drug Designation for DYNE-101 for the Treatment of Myotonic Dystrophy Type 1

September 20, 2023

From Dyne Therapeutics, Inc.

Via GlobeNewswire

Dyne Therapeutics to Present at Morgan Stanley 21st Annual Global Healthcare Conference

September 05, 2023

From Dyne Therapeutics, Inc.

Via GlobeNewswire

Dyne Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights

August 03, 2023

From Dyne Therapeutics, Inc.

Via GlobeNewswire

Dyne Therapeutics to Present at Jefferies Healthcare Conference

June 01, 2023

From Dyne Therapeutics, Inc.

Via GlobeNewswire

Dyne Therapeutics Receives European Medicines Agency (EMA) Orphan Drug Designation for DYNE-101

May 25, 2023

From Dyne Therapeutics, Inc.

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.